TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 4 | 1 | 8 | 7 | 40 | 70 | 135 | 43 |
S | %wins | 25 | 0 | 25 | 0 | 0 | 0 | 8 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/13 19:17 | 11/6/13 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | VP,Comme | S.d | -2,557 | 51.14 | 23 | -50 | -100 | 0 | D | 519 | 212 | 69 | 34 | 1 | -12 | -4 | -9 | 1 | 7 | -2 | 26 | 54 | 72 |
9/27/13 18:11 | 9/25/13 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | VP,Comme | S.d | -470 | 47.00 | 17 | -10 | -100 | 0 | D | 355 | 155 | 64 | 66 | 31 | 29 | 16 | 14 | 1 | 11 | 4 | 20 | 33 | 107 |
8/16/13 16:29 | 8/14/13 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | VP,Comme | S.d | -544 | 37.00 | 12 | -15 | -100 | 0 | D | 302 | 132 | 83 | 24 | 17 | 4 | -1 | 1 | 0 | 2 | 13 | 51 | 88 | 185 |
7/15/13 10:53 | 7/12/13 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | VP,Comme | S.d | -952 | 32.00 | 15 | -30 | -100 | 0 | D | 180 | 108 | 72 | 7 | 9 | 8 | 7 | 5 | 3 | 10 | 11 | 64 | 105 | 176 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |